Sick Dividends

Searching For Healthy Profits In The Stock Market

Sick Dividends. Big Pharma, High Dividend Stocks, High Growth Stocks, REITs, Closed End Funds & more.

SickDividends.com is a sister site of SickEconomics.com

SICK PICKS


Our favorite dividend shares in today’s stock market. Highlighting companies that stand to profit through  innovation, mismatches in share price to market potential, or just plain great economics.

(Stocks may be owned by the Sick Economist, or other commentators on this page.)

JNJ

Johnson and Johnson has been in business for 138 years, and is likely to be in business 138 years from now. This company represents a core part of America’s healthcare infrastructure, launching a dizzying array of novel medicines and cutting-edge medical devices. This American classic will be largely immune from controversies related to international trade, and the firm’s healthy balance sheet is likely to allow it to keep pumping out rising dividends no matter what kind of volatility the American economy endures. A sickly biotech sector may even allow J&J to snap up promising biotech startups at bargain prices, benefiting shareholders by lining the megafirm’s pipeline with exciting new drugs. With 10,000 Baby Boomers per day getting Medicare cards, the firm is set to enjoy unlimited demand for its products for years to come.

finviz dynamic chart for JNJ

Click On Chart To Expand

IRM

Iron Mountain stores paperwork and data for 95% of the Fortune 1000 companies. If information is the lifeblood of commerce, then IRM is essential to the continued survival of Global Business. The company’s legacy business (paper records storage) provides steady and recurring revenue, while the company’s growth businesses (digital storage and services) create the growth that investors need for the 21st century. Structured as a REIT, Iron Mountain constantly puts that growing cash flow right back into investors’ pockets.

finviz dynamic chart for IRM

Click On Chart To Expand

ROST

Ross Dress for Less is likely to survive, or even thrive, in a down economy. In an environment where all competitors import clothing, Ross is well positioned to sell designer and brand names at a lower price than anyone else. Economic pressure is likely to motivate a whole new generation of discount shoppers to try Ross, and they may well like what they find. Ross carries very little debt, and currently pays out only 23% of their profit in the form of dividends; meaning that Ross can likely outlast weaker competitors, while raising its dividend at, or above, the rate of inflation. Ross is a discount name that offers thrifty investors an opportunity to fill their baskets with profit.

finviz dynamic chart for ROST

Click On Chart To Expand

DIVIDEND GROWTH STOCKS


These stocks don’t always offer the highest dividend payout today, but they offer the strongest growth over time. These are a collection of healthy, rapidly growing businesses that will aim to increase their dividends year after year, decade after decade. These stocks will keep working for you, long after you have retired.

INFLATION CRUSHING STOCKS FOR THE TRUMP ERA

  Donald Trump’s hypothetical tariff proposals, coupled with his deportation policies, are expected to drive…

ABBOTT LABS: REAPING THE DIVIDENDS OF AN AGING PLANET

  By Herbert Han Cook    Introduction In the healthcare sector, Abbott Laboratories stands as…

ALPHABET, INC: A DIVIDEND STAR IS BORN?

  Hell has officially frozen over. Alphabet Inc (AKA, Google) has finally declared a dividend….

HIGH DIVIDEND STOCKS


These stocks pay high dividends today to maximize your current passive income. They can create a monthly or quarterly paycheck for you. They offer high income with low work on your part.

TOTAL ENERGIES: PREPARED FOR THE UNKNOWN

  Donald Rumsfeld, who held just about every major Federal Government cabinet post over a…

VERIZON COMMUNICATIONS INC: DIALING UP A HIGH DIVIDEND

  By Jose P. Lopez    Introduction….A Secure Connection?  Verizon Communications stands as one of…

HOW SAFE IS ABBVIE’S DIVIDEND?

  By Mackenzie Deming, Equity Analyst    Let’s talk about Abbvie– this company was derived…

THE BASICS OF INVESTING WITH RYAN JAMES


Junior equity analyst Ryan James seeks to empower the average investor through education. Ryan strives to explain the fundamentals of investing in simple language that anyone can understand. In these posts Ryan shares specific knowledge that will help you start down the road of financial independence.

APPLE: A FUTURE AI POWERHOUSE?

By Ryan James, Dividend Analyst Fellow   Big Tech’s Dominance The so-called “Magnificent Seven” stocks—Apple…

WHICH SEMICONDUCTOR STOCK WILL END UP ON TOP?

  By Ryan James, Dividend Analyst Fellow Market Ferver Currently, despite ongoing recession fears, large…

3M: IS THIS DIVIDEND KING LANGUISHING?

  By Ryan James, Dividend Analyst Fellow   Company History Founded in 1902, the multinational…

BIG PHARMA DIVIDENDS


Good for what ailes you. Many of these companies have been in business for a century or more, grinding out dependable and growing dividends over the decades. The perfect Rx for passive income.

SEARCHING FOR VALUE IN THE HEALTHCARE SECTOR

  “You don’t make money when you sell; you make money when you buy.” This…

J&J: THE NEXT ELI LILLY?

  By the Sick Economist   This wasn’t supposed to happen. It really shouldn’t be….

PFIZER, INC: A MISUNDERSTOOD STOCK?

  By Mackenzie Deming, Equity Analyst    The Pfizer public perception versus reality: let’s talk…

DIVIDEND REITs


These are special corporations with special rules, that focus exclusivly on real estate. From strip centers to single family homes to senior living, you can own it all with the click of a button. You can earn real passive income from real estate.

THREE REITS DELIVERING SAFETY IN AN UNCERTAIN WORLD

  By the Sick Economist   REITs have been a very popular income investment over…

WHAT TO DO ABOUT GRANDMA?

By the Sick Economist      Did you know that, as little as 100 years…

HIGH YIELD HEALTHCARE: AN INTERVIEW WITH JUSSI ASKOLA

Jussi Askola is the President of Leonberg Capital, a boutique investment research firm specializing in…

CLOSED END FUNDS


These are funds built just to maximize regular cash distributions. Many offer higher regular income that other kids of dividend paying securities. Open your eyes to cash flow opportunities with closed end funds.

NEW MOUNTAIN FINANCIAL: SOLID HIGH INCOME

  By The Sick Economist   Regarding financial crises, investing legend Warren Buffett once quipped,…

NAVIGATING NAV

By The Sick Economist   The concept of net asset value (“NAV”) in regards to…

CLOSED END FUNDS: SPECIAL VEHICLES FOR SPECIAL INCOME

By the Sick Economist   You really can visualize a Closed End Fund as a…

THE DIVIDEND EXPLAINER


 How can you make your money work hard for you? It’s not black magic that only works for Manhattan Socialites. With self directed study and determination, anyone can learn to achieve passive income, so that they are the master of their money, rather than the other way around.

3 DIVIDEND STOCKS THAT MIGHT BE SAFER THAN TREASURY BONDS, PART II

  With the United States currently experiencing a hurricane of instability, investors are starting to…

3 DIVIDEND STOCKS THAT MIGHT BE SAFER THAN TREASURY BONDS, PART I

Question: What is more nauseating than a roller coaster ride, but not nearly as much…

MASTERING THE PROXY STATEMENT, PART V (THE ELECTRIC BOOGALOO)

  In part one of this series, we learned all about the importance of the…

You understand that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. You further understand that none of the bloggers, information providers, app providers, or their affiliates are advising you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent that any of the content published on the Site may be deemed to be investment advice or recommendations in connection with a particular security, such information is impersonal and not tailored to the investment needs of any specific person. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Site will not contain a list or description of relevant risk factors.

The Site is not intended to provide tax, legal, insurance or investment advice, and nothing on the Site should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Sick Dividends or any third party. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should consult an attorney or tax professional regarding your specific legal or tax situation.

ACCEPT